Novel approaches of the nanotechnology-based drug delivery systems for knee joint injuries: A review.
Dendrimers
Exosomes
Knee joint injuries
Liposomes
Micelles
Nanoparticles
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
25 Oct 2021
25 Oct 2021
Historique:
received:
01
06
2021
revised:
14
08
2021
accepted:
23
08
2021
pubmed:
29
8
2021
medline:
13
10
2021
entrez:
28
8
2021
Statut:
ppublish
Résumé
The knee joint is one of the largest, most complex, and frequently utilized organs in the body. It is very vulnerable to injuries due to activities, diseases, or accidents, which lead to or cause knee joint injuries in people of all ages. There are several types of knee joint injuries such as contusions, sprains, and strains to the ligament, tendon injuries, cartilage injuries, meniscus injuries, and inflammation of synovial membrane. To date, many drug delivery systems, e.g. nanoparticles, dendrimers, liposomes, micelles, and exosomes, have been used for the treatment of knee joint injuries. They aim to alleviate or reverse the symptoms with an improvement of the function of the knee joint by restoring or curing it. The nanosized structures show good biodegradability, biocompatibility, precise site-specific delivery, prolonged drug release, and enhanced efficacy. They regulate cell proliferation and differentiation, ECM synthesis, proinflammatory factor secretion, etc. to promote repair of injuries. The goal of this review is to outline the finding and studies of the novel strategies of nanotechnology-based drug delivery systems and provide future perspectives to combat the challenges of knee joint injuries by using nanotechnology.
Identifiants
pubmed: 34454029
pii: S0378-5173(21)00857-7
doi: 10.1016/j.ijpharm.2021.121051
pii:
doi:
Substances chimiques
Micelles
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
121051Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.